Precision Medicine Market Size, Share, Trend & Growth Forecast to 2024

Market Study Report adds a new Precision Medicine Market Research Report for the period of 2017-2024 that shows the growth of the market is rising at a Steady CAGR to 2024.
Precision Medicine Market size is set to exceed USD 96 billion by 2024; according to a new research report.
Rising prevalence of cancer across the globe fuels the need to develop target specific biomarkers based on the individual genetic, environmental and lifestyle factors augmenting the global precision medicine market size. Advancement in cancer biology coupled with increased funding for cancer research will fuel industry expansion. For instance, in 2015 NIH's National Cancer Institute (NCI) invested USD 70 million to develop effective therapies for the treatment of cancer based on the individual genomic data.
Presence of favorable government initiatives such as Precision Medicine Initiative (PMI) with an aim to design tools for analyzing large medical data sets, validation of innovative targeted drugs, tests and technologies for cancer, improve decision making for treatment options for specific patients will augment growth of precision medicine market.
Integration of big data analytical tools to healthcare for preventing diseases such as cancer is another growth rendering driver. Moreover, rising adoption of gene therapy to reduce cost burden for such diseases will favor industry expansion. Excessive cost associated with precision medicine coupled with misinterpretation of genomic data will hamper business growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467588/
Companion diagnostics is poised to be the fastest growing segment with over 11.5% CAGR owing to its ability to provide essential information for the safety and effectiveness of a specific drug or therapeutic product for targeted patient groups.
CNS will show considerable growth over the coming years owing to the rising economic burden of central nervous system disorders which fosters the need to develop genomic platforms in combination with electronic health record data based on clinical phenotypes for effective targeted treatment of such diseases.
UK precision medicine market should witness robust growth over the forecast period. Favorable government initiatives and increasing funding on research activities such as the launch of stratified medicine initiative in 2011 with €60 million budget focused on biomarker, patient cohorts, genomic and phenotypic analysis will fuel regional growth. Further, the launch of 100,000 Genomes Project in 2012 by Genomics England with €250-300 million funding for genomics has paved the way for individualized treatment for cancer patients and escalate regional market size.
Request a sample of this premium report Total Station Instrument market at: https://www.marketstudyreport.com/request-a-sample/467588/
Table of Content:
Chapter 1. Methodology
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Market definition and forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
Chapter 2. Executive Summar
2.1. Precision medicine industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Technology trends
2.1.3. Application trends
2.1.4. Regional trends
Chapter 3. Precision Medicine Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Advancement in cancer biology
3.3.1.2. Rise in the online collaborative forum
3.3.1.3. Increased adoption of gene therapy
3.3.1.4. Advancements in big data analytics
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of precision medicine
3.3.2.2. Violation of the privacy rule and misinterpretation of genetic and health data
3.4. Growth potential analysis
3.4.1. By technology
3.4.2. By application
3.5. Regulatory landscape
3.5.1. U.S
3.5.2. Europe
3.6. Porter's analysis
3.7. Competitive landscape, 2016
3.7.1. Business overview
3.7.2. Revenue analysis
3.7.3. Product landscape
3.7.4. Strategy dashboard
3.8. PESTEL analysis
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: [email protected]
Web site: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/
Industry News: news.marketsizeforecasters.com